国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

   

Study tests hepatitis B vaccine

(Xinhua)
Updated: 2006-10-26 08:39

A second phase of clinical tests of China's hepatitis B vaccine are being carried out on 46 chronic hepatitis B patients to test the vaccine's effectiveness, said expert Wu Yuzhang.

The patients began treatment in June and will remain under close medical observation until the tests end next March, said Wu, head of the Immunology Institute of the People's Liberation Army.

The research team headed by Wu completed the first phase of clinical tests of the vaccine in June 2003. Nine months of monitoring found no safety concerns on a group of 52 healthy volunteers.

"The vaccine needs to go through a third phase of clinical tests before being put into production. The third phase of tests will be conducted on a larger group of hepatitis B patients to test safety and effectiveness," Wu said.

It is estimated that about 100 million Chinese are living with hepatitis B and about 20 million of them are chronic hepatitis B patients. Each year in China about 280,000 people die of cirrhosis or liver cancer linked to hepatitis B.

Wu said the hepatitis B global inoculation scheme being promoted by the World Health Organization is based on a preventive vaccine, which has no effect on infected people and fails to protect five to 15 percent of newborns.

The Chinese Foundation for Hepatitis Prevention and Control has invited Andy Lau, a famous Hong Kong star, who is carrying the hepatitis B virus, to be a publicity ambassador for the prevention and control of the disease.

The Chinese Ministry of Health has begun a yearlong nationwide survey of hepatitis B, to update guidelines on prevention and control of the disease.

On another liver virus, officials are calling hepatitis C a major public health threat in China. Health departments must do more to raise public awareness of the disease, an expert said in Beijing yesterday.

Hepatitis C is a serious threat to health in China and a public health challenge for the government, said Zhuang Hui, director of the Society of Hepatitis Diseases, attached to the Chinese Medical Association.

He called for the more active measures to prevent the disease and to monitor high risk groups such as medical workers, intravenous drug users, people with multiple sex partners and those who have received blood transfusions or organ transplants.

According to the national Center for Disease Control and Prevention, 40 million Chinese are carrying the hepatitis C virus. New infection cases jumped to about 60,000 in 2005 from 20,000 in 2003. Although acute symptoms are relatively mild compared with other types of hepatitis, it tends to become chronic and can develop into cirrhosis and liver cancer.


 
 

黑水县| 修文县| 民乐县| 清河县| 恭城| 江华| 岫岩| 云南省| 安乡县| 连江县| 原平市| 布尔津县| 甘德县| 红河县| 商河县| 襄汾县| 石河子市| 尼木县| 丽水市| 囊谦县| 宜都市| 木兰县| 府谷县| 漳州市| 察隅县| 龙游县| 马关县| 绍兴县| 绥江县| 方山县| 神农架林区| 山东省| 兴海县| 延寿县| 麻城市| 镇坪县| 漠河县| 英山县| 改则县| 东丽区| 宁化县|